May 7, 2021 10:50 UTC
ANI Pharmaceuticals Reports First Quarter 2021 Results
ANI Pharmaceuticals Reports First Quarter 2021 Results May 7, 2021 10:50 UTC ANI Pharmaceuticals Reports First Quarter 2021 Results -- First quarter 2021 net revenues of $54.5 million; net income of $0.1 million and diluted earnings per share of $0.01 -- -- First quarter adjusted non-GAAP EBITDA of $18.9 million and adjusted non-GAAP diluted earnings per share of $1.04 -- -- Cortrophin® Gel sNDA re-filing on track for Q2 2021 submission -- -- Strengthened R&D engine and enhanced generics and CDMO business through pending acquisition of Novitium Pharma-- -- Expanded branded products portfolio through April 1 acquisition of Sandoz Inc. NDAs -- -- Strengthened leadership team
May 7, 2021 11:00 UTC
AerSale Reports First Quarter 2021 Results
AerSale Reports First Quarter 2021 Results May 7, 2021 11:00 UTC AerSale Reports First Quarter 2021 Results First Quarter 2021 Highlights Revenue of $58.4 million. GAAP net income of $10.0 million, or 17.1% of sales. Adjusted EBITDA of $16.5 million, or 28.3% of sales. Continued strong demand for freighters and improving commercial activity. AerAware flight testing by FAA in progress. Finalizing the sale/lease of 18 Boeing 757s. 2021 guidance unchanged: revenue of $340 - $360 million and adjusted EBITDA of $60 - $70 million1. MIAMI--(BUSINESS WIRE)-- AerSale Corporation (Nasdaq: ASLE) (the “Company”) today reported results for the first quarter ended March 31, 202
May 7, 2021 12:00 UTC
Cinemark Announces New Agreements with All Five Major Studio Partners to Exhibit Films Theatrically
Cinemark Announces New Agreements with All Five Major Studio Partners to Exhibit Films Theatrically May 7, 2021 12:00 UTC Cinemark Announces New Agreements with All Five Major Studio Partners to Exhibit Films Theatrically Agreements secure a consistent supply of content and demonstrate a shared commitment to the theatrical moviegoing experience PLANO, Texas--(BUSINESS WIRE)-- Cinemark Holdings, Inc., one of the world’s largest and most influential movie theatre companies, today announced it has reached agreements to theatrically showcase films from all five major studio partners across its U.S. theatres. This announcement builds upon the exhibitor’s November agreement with U
May 7, 2021 10:00 UTC
Mednax Reports First Quarter Results
Mednax Reports First Quarter Results May 7, 2021 10:00 UTC Mednax Reports First Quarter Results FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.06 per share for the three months ended March 31, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.24. For the 2021 first quarter, Mednax reported the following results from continuing operations: Net revenue of $447 million; Income from continuing operations of $5 million; and Adjusted EBITDA of $45 million. “Our operating resul
May 7, 2021 13:00 UTC
DXP Enterprises Reports First Quarter 2021 Results
DXP Enterprises Reports First Quarter 2021 Results May 7, 2021 13:00 UTC DXP Enterprises Reports First Quarter 2021 Results $127.5 million in cash and cash equivalents $245.6 million in sales GAAP diluted EPS of $0.02, including significant tax reserves due to proposed state tax positions ($0.06 per share) Free cash flow for the quarter of $11.2 million HOUSTON--(BUSINESS WIRE)-- DXP Enterprises, Inc. (NASDAQ: DXPE) today announced financial results for the first quarter ended March 31, 2021. The following are results for the three months ended March 31, 2021, compared to the three months ended March 31, 2020 and December 31, 2020, where appropriate. A reconciliation of
May 7, 2021 10:45 UTC
TELUS International Reports First Quarter 2021 Results, Continued Strong Revenue Growth and Operating Performance; Provides Full Year Outlook
TELUS International Reports First Quarter 2021 Results, Continued Strong Revenue Growth and Operating Performance; Provides Full Year Outlook May 7, 2021 10:45 UTC TELUS International Reports First Quarter 2021 Results, Continued Strong Revenue Growth and Operating Performance; Provides Full Year Outlook Revenue of $505 million, up 57% year-over-year, driven by robust, double-digit organic growth, as well as strong contributions from recent acquisitions Acquisitions, digital, client mix, and efficiencies drove Adjusted EBITDA of $129 million, up 90% year-over-year; Net Income of $3 million and diluted EPS of $0.01 Adjusted diluted EPS of $0.23 was 229% higher year-over-year

Execution time: 0.3768 seconds
Layout: desktop